Oramed Pharmaceuticals Inc. (ORMP) Revenue History
Annual and quarterly revenue from 2013 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
ORMP Revenue Growth
ORMP Revenue Analysis (2013–2024)
As of May 8, 2026, Oramed Pharmaceuticals Inc. (ORMP) generated trailing twelve-month (TTM) revenue of $2.0 million. The most recent quarter (Q2 2025) recorded $0 in revenue, down 100.0% sequentially.
Looking at the longer-term picture, ORMP's historical revenue data shows various trends over time. The company achieved its highest annual revenue of $2.7 million in 2020.
When compared to Healthcare sector peers including MNKD (+21.2% YoY), NRXP, and NVO (+8.1% YoY). Compare ORMP vs MNKD →
ORMP Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| ORMPCurrent | $2M | - | - | - | |
 MNKD | $349M | +21.2% | +39.9% | 11.1% | |
 NRXP | $1M | - | - | -1324.4% | |
 NVO | $309.1B | +8.1% | +19.5% | 41.3% | |
 LLY | $65.2B | +47.4% | +21.6% | 45.6% |
ORMP Historical Revenue Data (2013–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $0 | -100.0% | $-193,000 | - | $-12,781,000 | - |
| 2023 | $1.3M | -50.4% | $1.3M | 100.0% | $-15,769,000 | -1176.8% |
| 2022 | $2.7M | +0.0% | $2.7M | 100.0% | $-40,598,000 | -1502.0% |
| 2021 | $2.7M | -0.3% | $2.7M | 100.0% | $-24,223,000 | -896.2% |
| 2020 | $2.7M | +0.3% | $2.6M | 96.7% | $-11,757,000 | -433.8% |
| 2019 | $2.7M | +10.4% | $2.6M | 96.7% | $-14,631,000 | -541.3% |
| 2018 | $2.4M | -0.3% | $2.4M | 96.5% | $-13,527,000 | -552.3% |
| 2017 | $2.5M | +283.2% | $2.3M | 92.4% | $-10,771,000 | -438.6% |
| 2016 | $641K | - | $151K | 23.6% | $-10,010,000 | -1561.6% |
| 2015 | $0 | - | $0 | - | $-7,383,000 | - |
See ORMP's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ORMP Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ORMP vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonORMP — Frequently Asked Questions
Quick answers to the most common questions about buying ORMP stock.
Is ORMP's revenue growth accelerating or slowing?
ORMP TTM revenue: $2M. YoY growth: N/A. 5-year CAGR: N/A.
What is ORMP's long-term revenue growth rate?
Oramed Pharmaceuticals Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is ORMP's revenue distributed by segment?
ORMP reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2013-2024 are available for download. Segment mix reveals concentration and diversification trends.